City Of Ecorse

ecorsemi.gov

City Of Ecorse is a Government Administration company located in 3869 W Jefferson Ave, Ecorse, Michigan, United States.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

GOVERNMENT BUSINESS

NASCIO AND ACCENTURE INITIATIVE SUPPORTS STATE GOVERNMENT CLOUD ADOPTION

Accenture | October 12, 2021

news image

A new biennial study by the National Association of State Chief Information Officers (NASCIO) and Accenture (NYSE:ACN) focuses on increased interest and use of cloud technologies in state governments and provides an assessment tool to help guide advancements in states’ use of cloud The 2021 Accenture and NASCIO Cloud Study notes that cloud first appeared on NASCIO’s State CIO Top Ten priorities list in 2010. Even with considerable uptake of cloud in many state governme...

Read More

GOVERNMENT BUSINESS

OMNISYNC SUCCESSFULLY COMPLETES PERFORMANCE UNDER ITS SECOND US AIR FORCE INNOVATION CONTRACT

OmniSync | February 25, 2022

news image

OmniSync Incorporated announces the successful completion of the period of performance under its second innovation contract from the US Air Force, fully meeting the objectives of both contracts. OmniSync is a San Diego-based high-growth tech startup that uses a combination of AI/ML-powered research tools, process workflow automation, and services to help democratize access to government grant and contract funds. Its flagship product, TurboSBIR is used by hundreds of deep tech and ...

Read More

HERE’S WHY TRUMP AND ELON MUSK SEE POTENTIAL IN A DRUG CALLED CHLOROQUINE TO TREAT CORONAVIRUS

CNBC | March 19, 2020

news image

When Dr. Mike Pellini, a physician and biotech investor, read the news about the spread of a virus that caused pneumonia-like symptoms, he decided to keep on hand a supply of an anti-malarial drug called chloroquine. Pellini, who tweeted about the decision to his followers in early February, was early to this thinking. A month later, Tesla CEO Elon Musk sparked massive interest in the drug after tweeting that chloroquine was “maybe worth considering” as a potential treatment for the ...

Read More

EMERGING TECHNOLOGY

BORQS TO ESTABLISH WITH THE U.S. GOVERNMENT A PLAN TO DIVEST ITS OWNERSHIP OF HOLU HOU ENERGY DUE TO DEEMED CRITICAL TECHNOLOGY

Borqs | December 20, 2022

news image

Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”, or the “Company”), a global provider of 5G wireless, Internet of Things (IoT) solutions, and innovative clean energy, today announced the Company has received a letter dated December 13, 2022 (the “Letter”) from the Department of the Treasury on behalf of the Committee on Foreign Investment in the United States (“CFIUS”) stating that the Company is required to negotiate with CFIUS to fully divest its...

Read More
news image

GOVERNMENT BUSINESS

NASCIO AND ACCENTURE INITIATIVE SUPPORTS STATE GOVERNMENT CLOUD ADOPTION

Accenture | October 12, 2021

A new biennial study by the National Association of State Chief Information Officers (NASCIO) and Accenture (NYSE:ACN) focuses on increased interest and use of cloud technologies in state governments and provides an assessment tool to help guide advancements in states’ use of cloud The 2021 Accenture and NASCIO Cloud Study notes that cloud first appeared on NASCIO’s State CIO Top Ten priorities list in 2010. Even with considerable uptake of cloud in many state governme...

Read More
news image

GOVERNMENT BUSINESS

OMNISYNC SUCCESSFULLY COMPLETES PERFORMANCE UNDER ITS SECOND US AIR FORCE INNOVATION CONTRACT

OmniSync | February 25, 2022

OmniSync Incorporated announces the successful completion of the period of performance under its second innovation contract from the US Air Force, fully meeting the objectives of both contracts. OmniSync is a San Diego-based high-growth tech startup that uses a combination of AI/ML-powered research tools, process workflow automation, and services to help democratize access to government grant and contract funds. Its flagship product, TurboSBIR is used by hundreds of deep tech and ...

Read More
news image

HERE’S WHY TRUMP AND ELON MUSK SEE POTENTIAL IN A DRUG CALLED CHLOROQUINE TO TREAT CORONAVIRUS

CNBC | March 19, 2020

When Dr. Mike Pellini, a physician and biotech investor, read the news about the spread of a virus that caused pneumonia-like symptoms, he decided to keep on hand a supply of an anti-malarial drug called chloroquine. Pellini, who tweeted about the decision to his followers in early February, was early to this thinking. A month later, Tesla CEO Elon Musk sparked massive interest in the drug after tweeting that chloroquine was “maybe worth considering” as a potential treatment for the ...

Read More
news image

EMERGING TECHNOLOGY

BORQS TO ESTABLISH WITH THE U.S. GOVERNMENT A PLAN TO DIVEST ITS OWNERSHIP OF HOLU HOU ENERGY DUE TO DEEMED CRITICAL TECHNOLOGY

Borqs | December 20, 2022

Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”, or the “Company”), a global provider of 5G wireless, Internet of Things (IoT) solutions, and innovative clean energy, today announced the Company has received a letter dated December 13, 2022 (the “Letter”) from the Department of the Treasury on behalf of the Committee on Foreign Investment in the United States (“CFIUS”) stating that the Company is required to negotiate with CFIUS to fully divest its...

Read More

Resources

resource image

GOVERNMENT BUSINESS, GOVERNMENT FINANCE

U.S. Engagement with WHO

Article

resource image

EMERGING TECHNOLOGY

Government as a driving force

Article

resource image

GOVERNMENT BUSINESS, GOVERNMENT FINANCE

U.S. Engagement with WHO

Article

resource image

EMERGING TECHNOLOGY

Government as a driving force

Article

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us